Dermapharm Holding SE - M&A Activity 2021

News Details

Ad-hoc | 7 July 2021 16:39

Dermapharm Holding SE acquires equity investment in CORAT Therapeutics GmbH

Dermapharm Holding SE / Key word(s): Investment

Dermapharm Holding SE acquires equity investment in CORAT Therapeutics GmbH

07-Jul-2021 / 16:39 CET/CEST

Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

Public disclosure of inside information in accordance with the amended version of Article 17(1) of Regulation (EU) No 596/2014 on market abuse (Market Abuse Regulation, “MAR”)

Dermapharm Holding SE acquires equity investment in CORAT Therapeutics GmbH

Grünwald, 7 July 2021 – Dermapharm Holding SE (WKN: A2GS5D, ISIN: DE000A2GS5D8) today, via Dermapharm AG, entered into an agreement to acquire an equity investment and new shares in CORAT Therapeutics GmbH, Braunschweig, Germany. Upon the completion of the capital increase, Dermapharm AG acquires 24.9% of the shares in the company, which is developing an antibody drug for treating COVID-19. The drug, which would be used to treat hospitalised patients with moderate to severe symptoms of COVID-19, is currently undergoing testing in a clinical phase Ib/II trial. It has been shown to reduce the viral load (SARS-CoV-2) in the lungs by 99.4%. The parties have agreed to keep the purchase price for the shares confidential.

>End of ad hoc disclosure<

Contact

Investor Relations & Corporate Communications

Britta Hamberger

Tel.: +49 (0)89 – 64186-233

Fax: +49 (0)89 – 64186-165

E-mail: [email protected]

07-Jul-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language:	English
Company:	Dermapharm Holding SE
	Lil-Dagover-Ring 7
	82031 Grünwald
	Germany
Phone:	+49 (0)89 64 86-0
E-mail:	[email protected]
Internet:	ir.dermapharm.de
ISIN:	DE000A2GS5D8
WKN:	A2GS5D
Indices:	SDAX
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange
EQS News ID:	1216404